G

GlaxoSmithkline Consumer Healthcare Ltd(Merged)

GSKCONS
This stock has been delisted or merged and is no longer actively traded.

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 44.9%

Weaknesses

3
  • Stock is trading at 10.9 times its book value
  • The company has delivered a poor sales growth of -0.36% over past five years.
  • Earnings include an other income of Rs.444 Cr.

Growth Rate

Revenue Growth
7% higher than 3Y
Net Income Growth
27% higher than 3Y

Quarterly Results

Particulars Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales
860
1,103
986
1,112
1,039
1,180
1,107
1,272
1,117
1,286
1,194
1,345
1,159
Expenses
693
885
819
853
832
930
877
918
878
968
914
949
887
Operating Profit
168
218
167
259
208
250
230
354
239
318
280
396
272
OPM %
19%
20%
17%
23%
20%
21%
21%
28%
21%
25%
23%
29%
23%
Other Income
56
70
55
57
61
84
96
89
124
123
127
78
116
Interest
1
1
1
1
0
1
0
0
0
0
2
2
1
Depreciation
17
18
17
18
15
15
15
15
16
15
20
20
19
PBT
206
269
204
298
253
319
312
427
347
426
386
452
367
Tax %
34%
35%
35%
35%
35%
34%
36%
36%
36%
33%
36%
24%
25%
Net Profit
136
176
132
192
164
212
200
275
221
286
248
345
277
EPS in Rs
32.4
41.78
31.41
45.7
38.87
50.31
47.61
65.44
52.51
67.89
58.93
82.02
65.71
Figures in ₹ Crores

Profit & Loss

Particulars Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014 15mMar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales
1,274
1,542
1,921
2,306
2,765
3,187
4,869
4,308
4,136
3,991
4,317
4,782
4,984
Expenses
1,049
1,308
1,611
1,932
2,261
2,614
3,996
3,569
3,298
3,153
3,433
3,641
3,718
Operating Profit
225
234
310
374
504
573
873
739
838
838
883
1,141
1,267
OPM %
18%
15%
16%
16%
18%
18%
18%
17%
20%
21%
20%
24%
25%
Other Income
69
98
89
120
85
114
207
213
278
239
257
433
444
Interest
5
5
4
3
3
2
1
1
2
3
2
1
5
Depreciation
43
42
42
40
46
36
63
62
57
64
64
60
74
PBT
245
284
354
452
540
649
1,016
889
1,056
1,010
1,074
1,512
1,631
Tax %
34%
34%
34%
34%
34%
33%
34%
34%
35%
35%
35%
35%
—
Net Profit
163
188
233
300
355
437
675
584
687
657
700
983
1,156
EPS in Rs
38.64
44.73
55.29
71.22
84.37
104
160
139
163
156
166
233
275
Div. Payout %
31%
34%
33%
70%
41%
43%
28%
40%
43%
45%
45%
45%
—
Figures in ₹ Crores

Balance Sheet

Particulars Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Equity Capital
42
42
42
42
42
42
42
42
42
42
42
42
42
Reserves
604
719
863
918
1,102
1,319
1,771
2,071
2,757
3,081
3,443
4,053
4,120
Borrowings
0
0
0
0
0
0
0
0
13
8
0
0
0
Other Liabilities
266
319
511
800
938
1,194
1,599
1,907
1,684
1,824
1,928
1,973
1,981
Total Liabilities
912
1,079
1,416
1,760
2,082
2,555
3,411
4,020
4,495
4,955
5,413
6,068
6,143
Fixed Assets
226
210
194
202
201
194
340
492
481
487
476
462
503
CWIP
17
16
38
108
149
197
38
42
51
58
38
18
15
Investments
298
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
371
853
1,184
1,450
1,733
2,163
3,033
3,486
3,963
4,410
4,899
5,588
5,625
Total Assets
912
1,079
1,416
1,760
2,082
2,555
3,411
4,020
4,495
4,955
5,413
6,068
6,143
Figures in ₹ Crores

Cash Flow

Particulars Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Operating
188
135
400
326
391
554
644
611
573
603
723
671
Investing
-21
19
-22
-79
-125
-377
-271
331
-152
-602
-446
-335
Financing
-63
-55
-30
-91
-248
-175
-223
-222
-286
-361
-363
-377
Net Cash Flow
104
99
349
156
17
2
150
720
136
-361
-87
-41
Free Cash Flow
163
105
355
218
295
472
477
506
521
537
674
638
CFO/OP
110
102
174
130
113
136
112
123
110
122
135
103
Figures in ₹ Crores

Ratios

Particulars Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Debtor Days
8
10
6
8
13
13
22
27
31
29
24
29
Inventory Days
222
238
178
170
171
148
108
114
125
160
127
148
Days Payable
164
148
191
194
166
192
178
185
213
303
312
303
Cash Conversion Cycle
66
100
-7
-16
18
-31
-48
-45
-57
-114
-161
-125
Working Capital Days
8
17
-30
-56
-42
-60
-39
-57
-36
-50
-65
-49
ROCE %
42%
41%
43%
48%
52%
52%
64%
46%
43%
34%
33%
40%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view GlaxoSmithkline Consumer Healthcare Ltd(Merged) insights

67 extracted metrics + investor summaries across FY07–FY19.

Log in — free

Shareholding Pattern

FIIs4.58%Promot.72.46%DIIs6.56%Public16.40%As ofDec 2019

Documents

Frequently Asked Questions about GlaxoSmithkline Consumer Healthcare Ltd(Merged)

What does GlaxoSmithkline Consumer Healthcare Ltd(Merged) do?
GlaxoSmithkline Consumer Healthcare is engaged in manufacturing and sale of healthcare consumer products.(Source : 201903 Annual Report Page No: 52)
Which sector does GlaxoSmithkline Consumer Healthcare Ltd(Merged) belong to?
GlaxoSmithkline Consumer Healthcare Ltd(Merged) is classified under the Fast Moving Consumer Goods sector, in the Food Products industry.

Company Information

GlaxoSmithkline Consumer Healthcare is engaged in manufacturing and sale of healthcare consumer products.(Source : 201903 Annual Report Page No: 52)

Website india-consumer.gsk.com/en-in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GSKCONS.md for GlaxoSmithkline Consumer Healthcare Ltd(Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Fast Moving Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List